OA08652A - Compositions, vaccine and monoclonal antibodies useful for the treatment of conditions caused by the HIV virus and methods for producing these antibodies and for diagnosing the presence of this virus. - Google Patents

Compositions, vaccine and monoclonal antibodies useful for the treatment of conditions caused by the HIV virus and methods for producing these antibodies and for diagnosing the presence of this virus.

Info

Publication number
OA08652A
OA08652A OA59183A OA59183A OA08652A OA 08652 A OA08652 A OA 08652A OA 59183 A OA59183 A OA 59183A OA 59183 A OA59183 A OA 59183A OA 08652 A OA08652 A OA 08652A
Authority
OA
OAPI
Prior art keywords
virus
vaccine
diagnosing
compositions
producing
Prior art date
Application number
OA59183A
Other languages
French (fr)
Inventor
Shriver Mary Kathleen
Elaine K Thomas
Wesley L Cosand
Larry H Gosting
Edna S Dickinson
Mcclure Janela
George J Todaro
Robert C Nowinski
Original Assignee
Soc D L Etat De Delaware Genet
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc D L Etat De Delaware Genet filed Critical Soc D L Etat De Delaware Genet
Publication of OA08652A publication Critical patent/OA08652A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
    • F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
    • F04B25/00—Multi-stage pumps
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1143—Gag-pol proteins, e.g. p17or p24
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/702—Specific hybridization probes for retroviruses
    • C12Q1/703—Viruses associated with AIDS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Mechanical Engineering (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
OA59183A 1986-08-20 1987-08-28 Compositions, vaccine and monoclonal antibodies useful for the treatment of conditions caused by the HIV virus and methods for producing these antibodies and for diagnosing the presence of this virus. OA08652A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US89827386A 1986-08-20 1986-08-20
US4502687A 1987-05-01 1987-05-01
US6799687A 1987-06-29 1987-06-29

Publications (1)

Publication Number Publication Date
OA08652A true OA08652A (en) 1988-11-30

Family

ID=27366600

Family Applications (1)

Application Number Title Priority Date Filing Date
OA59183A OA08652A (en) 1986-08-20 1987-08-28 Compositions, vaccine and monoclonal antibodies useful for the treatment of conditions caused by the HIV virus and methods for producing these antibodies and for diagnosing the presence of this virus.

Country Status (28)

Country Link
JP (1) JPS6485928A (en)
KR (1) KR920008744B1 (en)
AT (1) AT398080B (en)
AU (1) AU616156B2 (en)
BE (1) BE1000811A4 (en)
CH (1) CH675728A5 (en)
CS (1) CS275838B6 (en)
DE (1) DE3727703A1 (en)
DK (1) DK433087A (en)
ES (1) ES2010727A6 (en)
FI (1) FI873553A7 (en)
FR (1) FR2603107B1 (en)
GB (1) GB2196634B (en)
GR (1) GR871298B (en)
HU (1) HU214439B (en)
IE (1) IE60671B1 (en)
IL (1) IL83580A (en)
IT (1) IT1222518B (en)
LU (1) LU86972A1 (en)
NL (1) NL8701950A (en)
NO (2) NO300462B1 (en)
NZ (1) NZ221440A (en)
OA (1) OA08652A (en)
PL (1) PL155084B1 (en)
PT (1) PT85567B (en)
SE (1) SE506025C2 (en)
YU (1) YU152587A (en)
ZW (1) ZW15487A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP96A (en) * 1986-06-03 1990-08-12 The Usa Dept Of Commerce Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) * 1987-05-01 1992-07-16 Genetic Systems Corporation Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
CA1339857C (en) * 1987-05-29 1998-05-05 Cecily Rou-Yun Sun Monoclonal antibodies to gp120 which neutraleze hiv-1
US6657050B1 (en) 1987-05-29 2003-12-02 Tanox, Inc. Chimeric viral-neutralizing immunoglobulins
US5981278A (en) * 1987-05-29 1999-11-09 Tanox, Inc. Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
US5834599A (en) * 1987-05-29 1998-11-10 Tanox Biosystems, Inc. Immunoconjugates which neutralize HIV-1 infection
WO1989007112A1 (en) * 1988-01-26 1989-08-10 The United States Of America, As Represented By Th A synthetic antigen evoking anti-hiv response
CA1341285C (en) * 1988-02-12 2001-08-14 Chang Yi Wang Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) * 1988-04-25 1989-12-15 Merck & Co Inc Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
US5562905A (en) * 1988-04-26 1996-10-08 E. I. Du Pont De Nemours And Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (en) * 1988-04-26 1990-09-12 The Du Pont Merck Pharmaceutical Company Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (en) * 1988-06-06 1992-04-10 Pasteur Institut PEPTIDES HAVING PROTECTIVE PROPERTIES OF A PATHOGENIC VIRUS OF THE HIV TYPE IN SENSITIVE CELLS
WO1990003984A1 (en) * 1988-10-03 1990-04-19 Repligen Corporation Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
EP0421626A1 (en) * 1989-09-19 1991-04-10 Merck & Co. Inc. Vaccine for aids and hepatitis B
SE9000333D0 (en) * 1990-01-31 1990-01-31 Britta Wahren MONOCLONAL ANTIBODY
SE468168B (en) * 1990-02-20 1992-11-16 Replico Medical Ab HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS
JPH03271233A (en) * 1990-03-19 1991-12-03 Inst Pasteur Induction of protection against viral infection by synergy between viral envelope glycoproteins and peptides corresponding to neutralizing epitopes of the glycoproteins
CA2047042A1 (en) * 1990-07-19 1992-01-20 John Hannah Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) * 1990-07-19 1992-01-20 Steven S. Bondy Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (en) * 1991-09-30 1993-11-22 Nitto Denko Corp Hiv-related cyclic peptide and adsorption material obtained by immobilizing the same
DK0635027T3 (en) * 1992-03-27 2000-10-02 Advanced Immunit T Inc Peptide T and related peptides for the treatment of inflammation, including disseminated sclerosis
AU2006322656B2 (en) 2005-12-09 2012-03-08 Vectus Biosystems Limited VIP fragments and methods of use
JP5165751B2 (en) 2008-09-02 2013-03-21 日本特殊陶業株式会社 Spark plug
KR102727239B1 (en) * 2022-09-07 2024-11-07 한국세라믹기술원 Magnesium oxide powder and method for manufacturing the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9328391B1 (en) * 1984-08-22 2016-05-03 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Cloning and expression of HIV-1 DNA
GB8501473D0 (en) * 1985-01-21 1985-02-20 Pasteur Institut Cloned dna sequences
EP0387915B1 (en) * 1984-10-18 1993-03-10 Institut Pasteur F antigens of the human immunodeficiency virus, and their applications
CA1341482C (en) * 1984-10-31 2005-05-10 Paul A. Luciw Process for preparing fragments of aids-associated retroviruses
IE64785B1 (en) * 1985-04-08 1995-09-06 Genetic Systems Corp Expression of immunologically reactive viral proteins
ATE109512T1 (en) * 1985-04-08 1994-08-15 Genetic Systems Corp EXPRESSION AND DIAGNOSIS USING GAG-ENCODED PEPTIDES IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV.
NZ215867A (en) * 1985-04-19 1989-10-27 Hoffmann La Roche Aids envelope protein, dna vectors and method of production
KR910002374B1 (en) * 1985-04-29 1991-04-20 제네틱 시스템즈 코포레이션 Synthetic Antigens for the Detection of AIDS-Related Diseases
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides
EP0245362B1 (en) * 1985-10-24 1994-06-29 Ronald C. Kennedy Synthetic peptides and use for diagnosis and vaccination for aids and arc
EP0245459B1 (en) * 1985-11-07 1993-09-29 The President And Fellows Of Harvard College T-cell lymphotrophic virus protein and assay
US4772547A (en) * 1986-02-03 1988-09-20 Hoffmann-La Roche Inc. HTLV-III envelope peptides
US4734362A (en) * 1986-02-03 1988-03-29 Cambridge Bioscience Corporation Process for purifying recombinant proteins, and products thereof
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
IE63109B1 (en) * 1986-06-23 1995-03-22 Genetic Systems Corp Human monoclonal antibody to lymphadenopathy-associated virus
EP0255190A3 (en) * 1986-08-01 1990-08-29 Repligen Corporation Recombinant polypeptides and their uses, inclusing assay for aids virus
JPH0762031B2 (en) * 1986-12-30 1995-07-05 アメリカ合衆国 Synthetic peptides that induce cell-mediated immunity to AIDS virus and AIDS virus proteins

Also Published As

Publication number Publication date
PL267401A1 (en) 1988-07-21
FR2603107A1 (en) 1988-02-26
CH675728A5 (en) 1990-10-31
KR890002547A (en) 1989-04-10
AU7720187A (en) 1988-05-19
SE8703225D0 (en) 1987-08-19
NL8701950A (en) 1988-03-16
PT85567B (en) 1991-02-08
IL83580A (en) 1992-11-15
IE60671B1 (en) 1994-08-10
BE1000811A4 (en) 1989-04-11
KR920008744B1 (en) 1992-10-09
DK433087A (en) 1988-02-21
CS8706136A2 (en) 1990-08-14
ZW15487A1 (en) 1988-09-14
GB8719587D0 (en) 1987-09-23
NO934897L (en) 1993-12-29
IL83580A0 (en) 1988-01-31
FI873553A0 (en) 1987-08-17
JPS6485928A (en) 1989-03-30
GR871298B (en) 1988-01-12
CS275838B6 (en) 1992-03-18
IT1222518B (en) 1990-09-05
DK433087D0 (en) 1987-08-19
NO300462B1 (en) 1997-06-02
GB2196634A (en) 1988-05-05
GB2196634B (en) 1991-05-15
PT85567A (en) 1987-09-01
HU214439B (en) 1998-03-30
AT398080B (en) 1994-09-26
NO302176B1 (en) 1998-02-02
DE3727703A1 (en) 1988-05-05
HUT44619A (en) 1988-03-28
YU152587A (en) 1992-09-07
SE8703225L (en) 1988-02-21
NZ221440A (en) 1991-11-26
FR2603107B1 (en) 1992-04-24
LU86972A1 (en) 1988-03-02
SE506025C2 (en) 1997-11-03
IT8721678A0 (en) 1987-08-19
NO934897D0 (en) 1993-12-29
AU616156B2 (en) 1991-10-24
ATA208987A (en) 1994-01-15
FI873553L (en) 1988-02-21
NO873495L (en) 1988-02-22
ES2010727A6 (en) 1989-12-01
FI873553A7 (en) 1988-02-21
IE872219L (en) 1988-02-20
NO873495D0 (en) 1987-08-19
PL155084B1 (en) 1991-10-31

Similar Documents

Publication Publication Date Title
FR2603107B1 (en) COMPOSITIONS, VACCINE AND MONOCLONAL ANTIBODIES USEFUL FOR THE TREATMENT OF CONDITIONS BY HIV VIRUS AND METHODS OF PRODUCING THE SAME AND DIAGNOSING THE PRESENCE OF THE VIRUS
EP0671920A4 (en) ANTI-IDIOTYPIC ANTIBODIES AND DIAGNOSTIC AND THERAPEUTIC USE FOR CONDITIONS DUE TO HIV.
NO20073429L (en) Use of an antibody against interleukin-6 receptor for the preparation of a pharmaceutical composition
FI903865A0 (en) Ultrasonic contrast agents, the method of their preparation and their use as diagnostic agents
DZ712A1 (en) New 2-2 iminobisethanol derivatives useful as medicines, intermediates for their preparation and processes for the preparation of these derivatives and intermediates.
OA03930A (en) Process for the preparation of azapurinones.
BR7504887A (en) PROCESS FOR THE PREPARATION OF SINTERIZED CERAMICS, POLYCrystalline: SINTERIZED CERAMICS: SINTERIZED BIPhasic CERAMICS; AND RESTAURANT DENTAL COMPOSITION
FR2376147A1 (en) BICYCLIC PROSTAGLANDINS, USEFUL IN PARTICULAR AS ANTI-AGGLUTINANTS FOR BLOOD PLATES AND THEIR PREPARATION PROCESS
DE69034226D1 (en) Preparation process of huperzine A and its analogs and compounds useful thereto
DE3781652D1 (en) PREPARATION SUITABLE FOR TREATMENT OF COLONAL DISEASES.
FR2388563A1 (en) ADVANCED ACELLULAR VACCINES CONTAINING CAPSULAR POLYSACCHARIDES
DE3854267D1 (en) HIV-specific monoclonal antibodies and hybridomas for their production.
ES8608884A1 (en) A PROCEDURE FOR ELIMINATION OF THE VIRUS LAV.
DZ1407A1 (en) D-substituted derivatives of n, n'-ditrimethoxybenzoylepiperazine as well as their preparation process.
FI885868A7 (en) Method for detecting antibodies to the human immunodeficiency virus
DE69018617D1 (en) DERIVATIVES OF HYDROXYMETHOXYMANDELIC ACID (HMMA) AND HOMOVANILLIC ACID (HVA) AND ANTIBODIES PRODUCED THEREOF AND THEIR IMMUNOLOGICAL ANALYZES USING THEM.
DE3854857D1 (en) PREVENTION AND TREATMENT OF RETROVIRUS DISEASE
FR2619220B1 (en) SPECIFIC ANTIGENS OF LEISHMANIA AND THEIR PREPARATION METHOD, ANTIGENIC PROFILES CONTAINING THESE ANTIGENS AND THEIR APPLICATION TO THE DIAGNOSIS OF VISCERAL LEISHMANIOSES.
FI874273L (en) Novel monoclonal antibodies to IFN-omega, methods for their preparation and their use for the purification and detection of IFN-omega
BG44203A3 (en) Method for preparing of 2- oxyindol- 1- carboxamides
BE839252A (en) PROCESS FOR THE PREPARATION OF BENZ ALPHA -2,5-OXAZOCINES
FR2296640A1 (en) PROCESS FOR THE PREPARATION OF A-BROMOISOPROPYLIDENE 1A, 5A, 4-THIA-2,6-DIAZA (3,2,0) -2 HEPTENE-6 ACETATE 7-ONE OR THEIR ESTERS
NO871190L (en) PROCEDURE FOR THE PREPARATION OF PHARMACOLOGICALLY ACTIVE SUBSTITUTED ANILIDES.
FR2385799A1 (en) SYNCYTIAL RESPIRATORY VIRUS VACCINE
FR2599971B1 (en) PROCESS FOR OBTAINING IMMUNOLOGICAL MODULATORS FOR THE TREATMENT OF IMMUNE DEFICIENCIES CAUSED BY VIRUSES, AND PRODUCT THUS OBTAINED